Background Clostridium difficile is a leading cause of morbidity and mortality in several
countries. However, there are limited evidence characterizing its role as a global public …

Clostridium difficile is the most frequent cause of nosocomial antibiotic-associated diarrhea.
The incidence of C. difficile infection (CDI) has been rising worldwide with subsequent …

Triptolide (TP), a traditional Chinese medicine, has been reported to be effective in the
treatment of autoimmune diseases and exerting antineoplastic activity in several human …

Importance Fecal microbiota transplantation (FMT) has been shown to be effective in
treating relapsing or refractoryClostridium difficileinfection, but practical barriers and safety …

Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen
Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study | Clinical …

There has been a startling shift in the epidemiology of Clostridium difficile infection over the
last decade worldwide, and it is now increasingly recognized as a cause of diarrhea in the …

There has been dramatic change in the epidemiology of Clostridium difficile infection (CDI)
since the turn of the 21st century noted by a marked increase in incidence and severity …

This Clinical Report was retired July 2017. Most upper respiratory tract infections are caused
by viruses and require no antibiotics. This clinical report focuses on antibiotic prescribing …

Antibiotic-associated diarrhea (AAD) and Clostridum difficile infections (CDI) have been well
studied for adult cases, but not as well in the pediatric population. Whether the disease …

Background & Aims Fecal microbiota transplantation (FMT) is commonly used to treat
Clostridium difficile infection (CDI). CDI is an increasing cause of diarrheal illness in …